Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma

被引:15
|
作者
Sallinen, H. [1 ]
Janhonen, S. [1 ,2 ]
Polonen, P. [3 ]
Niskanen, H. [4 ]
Liu, O. H. [4 ]
Kivela, A. [4 ]
Hartikainen, J. M. [5 ]
Anttila, M. [1 ]
Heinaeniemi, M. [3 ]
Yla-Herttuala, S. [4 ]
Kaikkonen, M. U. [4 ]
机构
[1] Kuopio Univ Hosp, Dept Obstet & Gynecol, Kuopio, Finland
[2] Univ Eastern Finland, Inst Clin Med, Sch Med, Kuopio, Finland
[3] Univ Eastern Finland, Inst Biomed, Sch Med, Kuopio, Finland
[4] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, Kuopio 70211, Finland
[5] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio, Finland
基金
芬兰科学院;
关键词
HGSOC; Ovarian carcinoma; Metastasis; RNA sequencing; Transcriptome; EXPRESSION; CANCER; GENE; SUBTYPES; GATA4;
D O I
10.1186/s12885-019-6339-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background High grade serous ovarian carcinoma (HGSOC) is the most common subtype of epithelial ovarian cancers (EOC) with poor prognosis. In most cases EOC is widely disseminated at the time of diagnosis. Despite the optimal cytoreductive surgery and chemotherapy most patients develop chemoresistance, and the 5-year overall survival being only 25-35%. Methods Here we analyzed the gene expression profiles of 10 primary HGSOC tumors and 10 related omental metastases using RNA sequencing and identified 100 differentially expressed genes. Results The differentially expressed genes were associated with decreased embryogenesis and vasculogenesis and increased cellular proliferation and organismal death. Top upstream regulators responsible for this gene signature were NR5A1, GATA4, FOXL2, TP53 and BMP7. A subset of these genes were highly expressed in the ovarian cancer among the cancer transcriptomes of The Cancer Genome Atlas. Importantly, the metastatic gene signature was suggestive of poor survival in TCGA data based on gene enrichment analysis. Conclusion By comparing the gene expression profiles of primary HGSOC tumors and their matched metastasis, we provide evidence that a signature of 100 genes is able to separate these two sample types and potentially predict patient survival. Our study identifies functional categories of genes and transcription factors that could play important roles in promoting metastases and serve as markers for cancer prognosis.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Comparative molecular profiling of distant metastatic and non-distant metastatic lung adenocarcinoma
    Chen, Zhiming
    Chen, Gang
    Wang, Zhongqi
    Yu, Jianing
    Zhang, Henghui
    Mao, Beibei
    Ma, Haitao
    NEOPLASMA, 2021, 68 (02) : 253 - +
  • [42] Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets
    Vareslija, Damir
    Priedigkeit, Nolan
    Fagan, Ailis
    Purcell, Siobhan
    Cosgrove, Nicola
    O'Halloran, Philip J.
    Ward, Elspeth
    Cocchiglia, Sinead
    Hartmaier, Ryan
    Castro, Carlos A.
    Zhu, Li
    Tseng, George C.
    Lucas, Peter C.
    Puhalla, Shannon L.
    Brufsky, Adam M.
    Hamilton, Ronald L.
    Mathew, Aju
    Leone, Jose P.
    Basudan, Ahmed
    Hudson, Lance
    Dwyer, Roisin
    Das, Sudipto
    O'Connor, Darran P.
    Buckley, Patrick G.
    Farrell, Michael
    Hill, Arnold D. K.
    Oesterreich, Steffi
    Lee, Adrian V.
    Young, Leonie S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (04): : 388 - 398
  • [43] Whole transcriptome analysis of primary and metastatic osteosarcoma in the canine model
    Koshino, Akiko
    Kiupel, Matti
    Elemento, Olivier
    Dervisis, Nikolaos
    CANCER RESEARCH, 2012, 72
  • [44] Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma
    Negri, Gian Luca
    Grande, Bruno M.
    Delaidelli, Alberto
    El-Naggar, Amal
    Cochrane, Dawn
    Lau, Ching C.
    Triche, Timothy J.
    Moore, Richard A.
    Jones, Steven J. M.
    Montpetit, Alexandre
    Marra, Marco A.
    Malkin, David
    Morin, Ryan D.
    Sorensen, Poul H.
    JOURNAL OF PATHOLOGY, 2019, 249 (03): : 319 - 331
  • [45] The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases
    Stacey A. Cohen
    Ming Yu
    Kelsey Baker
    Mary Redman
    Chen Wu
    Tai J. Heinzerling
    Ralph M. Wirtz
    Elpida Charalambous
    George Pentheroudakis
    Vassiliki Kotoula
    Konstantine T. Kalogeras
    George Fountzilas
    William M. Grady
    Clinical Epigenetics, 2017, 9
  • [46] The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases
    Cohen, Stacey A.
    Yu, Ming
    Baker, Kelsey
    Redman, Mary
    Wu, Chen
    Heinzerling, Tai J.
    Wirtz, Ralph M.
    Charalambous, Elpida
    Pentheroudakis, George
    Kotoula, Vassiliki
    Kalogeras, Konstantine T.
    Fountzilas, George
    Grady, William M.
    CLINICAL EPIGENETICS, 2017, 9
  • [47] Integrative Genomic and Transcriptomic Characterization of Matched Primary and Metastatic Liver and Colorectal Carcinoma
    Roessler, Stephanie
    Lin, Guoling
    Forgues, Marshonna
    Budhu, Anuradha
    Hoover, Shelley
    Simpson, R. Mark
    Wu, Xiaolin
    He, Ping
    Qin, Lun-Xiu
    Tang, Zhao-You
    Ye, Qing-Hai
    Wang, Xin Wei
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2015, 11 (01): : 88 - 98
  • [48] Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors
    Aziz, Saadia A.
    Sznol, Joshua A.
    Adeniran, Adebowale
    Parisi, Fabio
    Kluger, Yuval
    Camp, Robert L.
    Kluger, Harriet M.
    BMC CLINICAL PATHOLOGY, 2013, 13
  • [49] Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy
    Harada, Kazuaki
    Okamoto, Wataru
    Mimaki, Sachiyo
    Kawamoto, Yasuyuki
    Bando, Hideaki
    Yamashita, Riu
    Yuki, Satoshi
    Yoshino, Takayuki
    Komatsu, Yoshito
    Ohtsu, Atsushi
    Sakamoto, Naoya
    Tsuchihara, Katsuya
    BMC CANCER, 2019, 19 (1)
  • [50] Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy
    Kazuaki Harada
    Wataru Okamoto
    Sachiyo Mimaki
    Yasuyuki Kawamoto
    Hideaki Bando
    Riu Yamashita
    Satoshi Yuki
    Takayuki Yoshino
    Yoshito Komatsu
    Atsushi Ohtsu
    Naoya Sakamoto
    Katsuya Tsuchihara
    BMC Cancer, 19